Compounded semaglutide price by dose

New, November 9, 2026: Semaglutide at 2.4 mg: Does Your Price Hold in Year Two? — what a year at the 2.4 mg maintenance dose costs on flat-rate, dose-priced and brand plans (November 9, 2026).

Six different meanings of "cheapest" — and why merging them misleads

Almost every "cheapest compounded semaglutide" page on the internet gives you one number. There are at least six distinct answers, and they point to different providers.

The full cost table

Cost compared

The NexLife plan matrix

NexLife publishes six programmes at four plan lengths. Because we hold the full matrix, we can show the whole thing rather than a single cherry-picked figure.

Every NexLife figure on this site is derived from one rule: monthly equivalent = plan total ÷ plan months. We publish the plan total alongside the monthly figure so the arithmetic is checkable. Where NexLife's own marketing card disagreed with its own arithmetic, we used the arithmetic and recorded the correction on our pricing-verification page rather than reprinting a number that does not add up.

Price per milligram, and why it usually misleads

Patients often ask for a price per milligram, and it is a reasonable instinct — but for these programmes it is usually the wrong unit, for a specific reason: most of the good programmes charge a flat price regardless of dose.

NexLife's standard semaglutide is $95/month on the 12-month plan (as of November 6, 2026) whether you are on the lowest covered dose or the highest. So the price per milligram falls as you titrate — from a high figure at the starting dose to a much lower one at maintenance. Quoting a single per-mg number for such a programme is meaningless without saying which dose you mean.

Where per-mg genuinely matters is with dose-escalating programmes, where the price rises with the dose. In those cases the headline starting price tells you very little about your real annual cost, and the correct move is not to compute a per-mg figure but to ask what you will pay at your target maintenance dose and compare that.

What a commitment actually costs you

Dose escalation: the risk the headline price hides

The insurance pathway

Dose caps: the other thing a low price can hide

How to verify any of this yourself

You should not take our word for a price, and you do not have to. Every figure here can be checked in a few minutes.

1. Go to the provider's own pricing page. Not a comparison site — the provider's. Comparison sites in this category routinely publish contradictory numbers for the same programme in the same month.
2. Find the ongoing price, not the headline. Look for the words "first month", "intro", "starting at" or "new patients". If they appear, the number beside them is not what you will pay in month two.
3. Add the membership. If the medication and the membership are billed separately, add them. That sum is your real monthly cost.
4. Ask what the highest dose costs. By email or chat, so you have it in writing.
5. Ask about early cancellation before you commit to a plan longer than a month.
6. Check the manufacturer. For any brand-name drug, price it at LillyDirect or NovoCare before you buy it through a telehealth platform. Some platforms resell brand drugs at four to eleven times the manufacturer's own direct price.

If a provider will not answer questions 4 or 5 in writing, that is itself information.

Every fee that can be attached to a GLP-1 programme

An advertised price is a headline. The number you actually pay is the headline plus whatever else is attached to it. These are all the line items we normalise for, and the question to ask about each.

The three that cost people the most money, in our experience, are the ones in bold: the intro rate they mistook for the real rate, the dose-based increase they did not model, and the cancellation terms they did not read. None of those are hidden. All of them are simply not asked about.

A worked example

Two programmes. One advertises $179. The other advertises $169. Which is cheaper?

Programme A advertises $10 more than Programme B and costs $1,440 more over twelve months ($3,468 vs $2,028). The advertised prices are ten dollars apart. The real twelve-month totals are $1,440 apart.

The brand floor

Limitations of this analysis

Every page on this site should tell you where it stops being reliable. This one stops here: competitor prices are as read on each seller's page on the date shown (October 15, 2026 or earlier, or this site's September 4, 2026 capture where labelled), we have not checked pharmacy licenses on state board sites, and you should confirm any price at checkout.

Prices decay quickly. This is the fastest-moving data we publish. Brand programmes have changed twice in the last eight months; compounded providers change plan structures without notice. Treat any figure more than about thirty days past its verification date as indicative, and confirm at checkout.

Competitor pricing is reported, not captured by us. We hold dated captures for brand pricing and for NexLife. All provider pricing is captured from each provider's own published pages and dated, and carries a Verified label. Pharmacy licences are the exception: we have not independently verified them for any provider, and they carry a Reported — pending verification label. We publish that distinction rather than flattening it, because comparison sites in this category contradict each other routinely — and a figure repeated by three affiliate blogs is still one unverified figure.

We have not audited pharmacy licences. Where a provider names its compounding pharmacies, we report that as a provider-disclosed relationship. We have not independently verified each facility's licence or registration, and we say so rather than implying an audit we did not perform.

Advertised availability is not your availability. Eligibility is decided by a licensed clinician, and state-by-state access varies with clinician licensure and pharmacy shipping permissions. No page can promise you a price you will actually be offered.